Polymorphic Light Eruption
8
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
83.3%
-3.2% vs benchmark
25%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Protective Effect Assessment of Foto Ultra Isdin Solar Allergy Fusion Fluid on the UVA Induced PLE
Skin Microbiome and Polymorphic Light Eruption
Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE)
Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases
Vitamin D Supplementation in Polymorphic Light Eruption
Regulatory T Cells (Tregs) in Polymorphic Light Eruption
Calcipotriol and Polymorphic Light Eruption
Sunscreen and After-sun-lotion Protection in Polymorphic Light Eruption